Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pain 5Agnosia 4Pain, Postoperative 3Lung Neoplasms 3Colonic Neoplasms 2Cancer Pain 2Acute Pain 2Trigger Finger Disorder 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Skin Neoplasms 1Rectal Neoplasms 1Patient Satisfaction 1Parathyroid Neoplasms 1Parathyroid Diseases 1Opioid-Related Disorders 1Neoplasms 1Multiple Myeloma 1Menorrhagia 1Median Neuropathy 1Leiomyoma 1Ileus 1Hemorrhage 1Head and Neck Neoplasms 1Goiter 1Ganglion Cysts 1Fever 1Emergence Delirium 1Diverticulosis, Colonic 1

Interventions

acetaminophen, codeine drug combination 1Tramadol 1Sublocade 1Capsules 1Buprenorphine, Naloxone Drug Combination 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Opioid-Related Disorders × Acetaminophen × Clear all
NCT03469310 2021-05-11

Minimizing Narcotic Analgesics After Endocrine Surgery

DHR Health Institute for Research and Development

Phase 4 Completed
126 enrolled
Head & Neck

Agnosia, Goiter, Opioid-Related Disorders, Parathyroid Diseases, Parathyroid Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡